Sumiko Yoshida Selected Research

nervonic acid

1/2021	Nervonic acid level in cerebrospinal fluid is a candidate biomarker for depressive and manic symptoms: A pilot study.
1/2018	Plasma Nervonic Acid Is a Potential Biomarker for Major Depressive Disorder: A Pilot Study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sumiko Yoshida Research Topics

Disease

17	Major Depressive Disorder (Major Depressive Disorders) 01/2021 - 07/2012
16	Schizophrenia (Dementia Praecox) 01/2022 - 10/2004
12	Bipolar Disorder (Manic Depressive Psychosis) 05/2021 - 01/2017
9	Inflammation (Inflammations) 05/2021 - 02/2010
9	Mental Disorders (Mental Disorder) 01/2020 - 02/2014
6	Insulin Resistance 01/2021 - 02/2010
6	Fibrosis (Cirrhosis) 10/2018 - 01/2008
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 10/2009
6	Atherosclerosis 01/2018 - 09/2010
5	Diabetes Mellitus 12/2021 - 01/2011
5	Ischemia 01/2018 - 10/2012
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 07/2022 - 11/2012
4	Alzheimer Disease (Alzheimer's Disease) 02/2022 - 01/2017
4	Obesity 01/2021 - 01/2011
4	Carotid Artery Diseases 04/2016 - 04/2009
3	Cognitive Dysfunction 02/2022 - 01/2011
3	Heart Failure 01/2021 - 10/2009
3	Multiple Myeloma 01/2019 - 11/2017
3	Neoplasms (Cancer) 11/2017 - 12/2008
2	Albuminuria 12/2021 - 06/2011
2	Sarcopenia 09/2021 - 09/2019
2	Atrial Fibrillation 01/2021 - 04/2010
2	Mood Disorders (Mood Disorder) 01/2021 - 01/2018
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2019 - 02/2010
2	Left Ventricular Dysfunction 10/2018 - 02/2011
2	Peripheral Arterial Disease 12/2014 - 04/2009
2	Hyperlipidemias (Hyperlipidemia) 06/2011 - 01/2011
2	Systemic Scleroderma (Systemic Sclerosis) 03/2011 - 01/2010
2	Vascular Remodeling 01/2011 - 06/2009
2	Hypertension (High Blood Pressure) 01/2011 - 01/2008
2	Hypertrophy 04/2010 - 01/2008
2	Psychotic Disorders (Schizoaffective Disorder) 09/2007 - 10/2004
2	Substance-Related Disorders (Drug Abuse) 09/2007 - 10/2004
1	Mania (Manias) 01/2021
1	Graves Disease (Basedow Disease) 01/2021

Drug/Important Bio-Agent (IBA)

17	Biomarkers (Surrogate Marker)IBA 02/2022 - 02/2011
8	Proteins (Proteins, Gene)FDA Link 02/2022 - 06/2003
8	Pharmaceutical PreparationsIBA 01/2020 - 03/2002
7	AndrogensIBA 01/2021 - 06/2009
5	Insulin (Novolin)FDA Link 07/2022 - 02/2009
5	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 02/2010
4	Thrombin FDA Link 12/2021 - 02/2010
4	Angiotensin IIIBA 10/2018 - 01/2008
4	pitavastatin (itavastatin)FDA Link 01/2018 - 01/2008
3	Amyloid (Amyloid Fibrils)IBA 02/2022 - 01/2017
3	AlbuminsIBA 12/2021 - 02/2010
3	Heparin Cofactor IIIBA 12/2021 - 04/2009
3	AdiponectinIBA 01/2021 - 08/2013
3	Testosterone (Sustanon)FDA Link 01/2021 - 07/2010
3	CytokinesIBA 01/2020 - 02/2010
3	lysophosphatidic acidIBA 05/2019 - 01/2019
3	Hemoglobins (Hemoglobin)IBA 01/2018 - 07/2012
3	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2018 - 04/2010
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 01/2008
3	Androgen Receptors (Androgen Receptor)IBA 07/2013 - 06/2009
2	CreatinineIBA 12/2021 - 06/2011
2	LipidsIBA 04/2021 - 01/2018
2	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2021 - 07/2012
2	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2021 - 01/2018
2	Glial Cell Line-Derived Neurotrophic Factor (GDNF)IBA 01/2021 - 01/2020
2	Becaplermin (PDGF-BB)FDA Link 01/2021 - 01/2011
2	nervonic acidIBA 01/2021 - 01/2018
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2020 - 07/2013
2	Antipsychotic Agents (Antipsychotics)IBA 01/2020 - 08/2012
2	Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA 01/2020 - 01/2017
2	Apolipoprotein L1IBA 12/2019 - 10/2019
2	oxidized low density lipoproteinIBA 10/2019 - 02/2010
2	Triglycerides (Triacylglycerol)IBA 01/2019 - 06/2011
2	Peptides (Polypeptides)IBA 01/2019 - 10/2018
2	Oxytocin (Pitocin)FDA LinkGeneric 01/2018 - 08/2012
2	Amino Acids FDA Link 01/2018 - 01/2015
2	Collagen Type I (Type I Collagen)IBA 04/2016 - 06/2009
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2014 - 07/2013
2	AdipokinesIBA 12/2014 - 08/2014
2	Interleukin-6 (Interleukin 6)IBA 03/2013 - 02/2010
2	LDL CholesterolIBA 06/2011 - 02/2010
2	Bosentan (Tracleer)FDA Link 03/2011 - 01/2010
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2011 - 02/2010
2	Biological ProductsIBA 09/2010 - 02/2009
2	Nitric Oxide Synthase (NO Synthase)IBA 04/2010 - 06/2009
2	Transforming Growth Factor beta (TGF-beta)IBA 06/2009 - 01/2008
2	Paclitaxel (Taxol)FDA LinkGeneric 12/2008 - 06/2008
2	Methamphetamine (Desoxyn)FDA LinkGeneric 09/2007 - 10/2004
1	DNA (Deoxyribonucleic Acid)IBA 07/2022
1	Fatty Acid-Binding ProteinsIBA 12/2021
1	Insulin-Like Growth Factor I (IGF-1)IBA 09/2021
1	LipopolysaccharidesIBA 04/2021
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2021
1	LithiumIBA 01/2021
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2021
1	landiololIBA 01/2021
1	Potassium Iodide (Pima)FDA Link 01/2021
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2021
1	Methimazole (Thiamazole)FDA LinkGeneric 01/2021
1	Prednisolone (Predate)FDA LinkGeneric 01/2021
1	GonadotropinsIBA 01/2021

Therapy/Procedure

6	Therapeutics 01/2021 - 12/2008
2	Communication Aids for Disabled (TDD) 02/2022 - 11/2012
2	Lasers (Laser) 08/2013 - 10/2012
1	Injections 02/2022